Temperature-controlled laminar airflow (TLA) device in the treatment of children with severe atopic eczema: Open-label, proof-of-concept study
Clinical & Experimental Allergy Feb 03, 2018
Gore C, et al. - In this study, researchers assessed the impact of the temperature-controlled laminar airflow (TLA) treatment in children/adolescents with severe atopic eczema (AE). They concluded that addition of TLA device to standard pharmacological treatment may be effective for managing difficult-to-control AE.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries